We aim to provide transparency in how Elevance Health plans address variations in clinical practices to ensure safe, ...

Data fragmentation and inefficiency are most evident in the quality reporting approach currently used for accountable care ...

Margolis Center for Health Policy to the pod to discuss her recent Forefront article focused on how ACO REACH enabled ACOs to ...

Join Health Affairs on December 11 for a virtual event examining private equity’s impact on the practice of medicine.

The majority of promotional expenditures are invested in drug samples, one of the industry’s most important marketing tactics ...

Taylor holds a bachelor’s degree from the University of Washington (UW) School of Engineering in technical communication and a master’s degree in clinical informatics and patient-centered technology ...

Geoffrey Crawford serves as Staff Vice President of Medical Policy (US) for The Elevance Health Companies, Inc.

When the sole manufacturer withdrew a critical cancer drug from Medicare and Medicaid, patients were left without options.

In late August 2025, CMS released Performance Year (PY) 2024 data for the Medicare Shared Savings Program (MSSP). This marked ...

A 2026 CMS proposed rule contains multiple provisions that will improve the transparency of hospital prices and support the ...

The No UPCODE Act—with some refinements—is a good start insofar it establishes some key pieces of reform, but a broader ...

With collaboration and evidence-based approaches, we can build a patient-centric health care system that works better for ...